Eye care pharmaceutical company Harrow sells off non-ophthalmic asset

Eye care pharmaceutical company Harrow has sold its non-ophthalmic compounding business to Innovation Compounding Pharmacy, an affiliate of Revelation Pharma Corporation. 

Read the full post on Becker's ASC